Siva Ent Hospital Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 27-05-2024
- Paid Up Capital ₹ 1.16 M
as on 27-05-2024
- Company Age 36 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.44 M
as on 27-05-2024
- Revenue 21.04%
(FY 2017)
- Profit -142.53%
(FY 2017)
- Ebitda 1.39%
(FY 2017)
- Net Worth -3.97%
(FY 2017)
- Total Assets -4.34%
(FY 2017)
About Siva Ent Hospital
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.16 M.
The company has closed loans amounting to ₹0.44 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Chandralekha Kumaresan and Navin Bharath serve as directors at the Company.
- CIN/LLPIN
U85110TN1988PTC015963
- Company No.
015963
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jul 1988
- Date of AGM
13 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Siva Ent Hospital Private Limited offer?
Siva Ent Hospital Private Limited offers a wide range of products and services, including Medical Surgery & Treatment Centres, Medical Treatment Services, Medical Consultants & Clinics, Health Care Service, Corporate and Soft Skills Training, Corporate Training, Tour Packages, Educational Tour Operating Services, Project Consultants, Teacher Training Program.
Who are the key members and board of directors at Siva Ent Hospital?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandralekha Kumaresan  | Director | 07-Jul-1988 | Current |
| Navin Bharath | Director | 28-May-2008 | Current |
Financial Performance of Siva Ent Hospital.
Siva Ent Hospital Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 21.04% increase. The company also saw a substantial fall in profitability, with a 142.53% decrease in profit. The company's net worth dipped by a decrease of 3.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Siva Ent Hospital?
In 2017, Siva Ent Hospital had a promoter holding of 99.01% and a public holding of 0.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sunaram Finance Ltd. Creation Date: 23 Aug 2004 | ₹0.44 M | Satisfied |
How Many Employees Work at Siva Ent Hospital?
Unlock and access historical data on people associated with Siva Ent Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siva Ent Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siva Ent Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
